The Broad Institute and NVIDIA Bring NVIDIA Clara to Terra Cloud Platform Serving 25,000 Researchers Advancing Biomedical Discovery
September 20 2022 - 12:15PM
GTC—NVIDIA today announced a partnership with the
Broad Institute of MIT and Harvard to provide the Terra cloud
platform and its over 25,000 users — from biomedical researchers in
academia, startups and large pharma companies — with the AI and
acceleration tools needed to quickly analyze massive amounts of
healthcare data.
The collaboration is designed to connect NVIDIA’s AI expertise
and healthcare computing platforms with the Broad Institute’s
world-renowned researchers, scientists and open platforms with a
focus on three key areas:
- Making NVIDIA Clara™
Parabricks® available in the Terra
platform: Parabricks, a GPU-accelerated software suite for
secondary analysis of sequencing data, is now available in six new
Terra workflows. Users can now analyze a whole genome in just over
one hour with Clara Parabricks compared to 24 hours in a CPU-based
environment and can reduce the compute cost by more than half.
- Building large language models (LLMs):
Researchers will develop foundational models for DNA and RNA, the
building blocks of life, to better understand human biology using
NVIDIA BioNeMo, an AI application framework announced today for
LLMs in biology.
- Bringing improved deep learning to Genome Analysis
Toolkit (GATK): NVIDIA is contributing a new deep learning
model directly to the Broad Institute’s GATK toolkit, the industry
standard used by more than 100,000 researchers, which helps
identify genetic variants that are associated with diseases. This
will help drug discovery researchers develop new therapies.
“There’s a need across the healthcare ecosystem for better
computational tools to enable breakthroughs in the way we
understand disease, develop diagnostics and deliver treatments,”
said Kimberly Powell, vice president of healthcare at NVIDIA. “By
expanding our collaboration with the Broad Institute, we can bring
the power of large language models to ultimately deliver joint
solutions and narrow the divide between insights from researchers
and real benefits for patients.”
The Broad Institute aims to enable the next generation of
collaborative biomedical research by providing an open cloud
platform that connects researchers both to each other and to the
datasets and tools they need to achieve scientific
breakthroughs.
“Life sciences are in the midst of a data revolution, and
researchers are in critical need of a new approach to bring machine
learning into biomedicine,” said Anthony Philippakis, chief data
officer of the Broad Institute. “In this collaboration, we aim to
expand our mission of data sharing and collaborative processes to
scale genomics research.”
Large Language Models to Study Disease NVIDIA’s
BioNeMo framework includes pretrained LLMs for proteins and
chemistry that simplify training, inference and scaling. BioNeMo is
an extension of the NVIDIA NeMo Megatron framework and is
domain-specific for chemistry, proteins and DNA/RNA sequences.
BioNeMo allows developers to effectively train and deploy
biology LLMs with billions of parameters. Together, teams from
both organizations will build on this work, creating new models to
add to the BioNeMo collection and make available in the Terra
platform.
NVIDIA Software for Domain-Specific AINVIDIA
Parabricks GPU-accelerated workflows provide researchers with
faster turnaround times and lower costs for a wide range of genomic
data analyses. For Broad’s GATK best practices germline workflow,
doing the analysis with Parabricks on GPUs can be as much as 24x
faster and less than half the cost.
Broad Institute researchers will also gain access to MONAI, an
open-source deep learning framework for medical imaging AI, as well
as NVIDIA RAPIDS™, a GPU-accelerated data science toolkit for
faster data preparation, which can be used for genomic single-cell
analysis.
Learn more about Clara Parabricks and Terra integration and sign
up for early access to the NVIDIA BioNeMo LLM service.
Tune in to NVIDIA CEO Jensen Huang’s GTC keynote to learn more
about the collaboration with the Broad Institute.
About NVIDIASince its founding in 1993, NVIDIA
(NASDAQ: NVDA) has been a pioneer in accelerated computing. The
company’s invention of the GPU in 1999 sparked the growth of the PC
gaming market, redefined computer graphics and ignited the era of
modern AI. NVIDIA is now a full-stack computing company with
data-center-scale offerings that are reshaping industry. More
information at https://nvidianews.nvidia.com/.
For further information, contact:Janette
CiborowskiNVIDIA
Corporation+1-734-330-8817jciborowski@nvidia.com
Certain statements in this press release including, but not
limited to, statements as to: the benefits and impact of our
partnerships including with the Broad Institute and the integration
of Clara Parabricks with Terra; the benefits, performance, impact
and availability of our products and technologies, including NVIDIA
Clara Parabricks, NVIDIA BioNeMo, NVIDIA NeMo Megatron and NVIDIA
RAPIDS; a data revolution in the life sciences; and the need for
better computational tools across the healthcare ecosystem are
forward-looking statements that are subject to risks and
uncertainties that could cause results to be materially different
than expectations. Important factors that could cause actual
results to differ materially include: global economic conditions;
our reliance on third parties to manufacture, assemble, package and
test our products; the impact of technological development and
competition; development of new products and technologies or
enhancements to our existing product and technologies; market
acceptance of our products or our partners' products; design,
manufacturing or software defects; changes in consumer preferences
or demands; changes in industry standards and interfaces;
unexpected loss of performance of our products or technologies when
integrated into systems; as well as other factors detailed from
time to time in the most recent reports NVIDIA files with the
Securities and Exchange Commission, or SEC, including, but not
limited to, its annual report on Form 10-K and quarterly reports on
Form 10-Q. Copies of reports filed with the SEC are posted on the
company's website and are available from NVIDIA without charge.
These forward-looking statements are not guarantees of future
performance and speak only as of the date hereof, and, except as
required by law, NVIDIA disclaims any obligation to update these
forward-looking statements to reflect future events or
circumstances.
© 2022 NVIDIA Corporation. All rights reserved. NVIDIA, the
NVIDIA logo, NVIDIA Clara, NVIDIA RAPIDS and Parabricks are
trademarks and/or registered trademarks of NVIDIA Corporation in
the U.S. and other countries. Other company and product names may
be trademarks of the respective companies with which they are
associated.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/8e4398fd-e335-4c7e-9f73-221dc9b9c823
NVIDIA (NASDAQ:NVDA)
Historical Stock Chart
From Aug 2024 to Sep 2024
NVIDIA (NASDAQ:NVDA)
Historical Stock Chart
From Sep 2023 to Sep 2024